Colloquially termed 'fungal acne', Malassezia folliculitis is an opportunistic infection of the hair follicle caused by lipophilic yeasts of the genus Malassezia (predominantly M. globosa and M. restricta). Because its clinical presentation mimics microcomedonal acne vulgaris, it is frequently misdiagnosed and mistreated with conventional antibacterial acne therapies.
Differential Diagnostic Indicators
- Monomorphic Morphology: Uniform, tiny (1–2mm) dome-shaped papulopustules without comedones or blackheads.
- Pruritus (Itching): Up to 80% of patients report notable itching or tingling, especially during sweating or humidity.
- Anatomical Distribution: Common on the upper forehead, hairline, chest, shoulders, and upper back.
- Resistance to Antibacterials: Topical clindamycin, doxycycline, and traditional benzoyl peroxide frequently fail or exacerbate the condition by disrupting the bacterial-fungal balance.
The Lipid Feeding Mechanism & Safe Formulations
Malassezia species lack fatty acid synthase genes and rely on exogenous free fatty acids with carbon chain lengths between C12 and C24 to survive. Most plant oils, fatty alcohols, and esters fuel fungal growth. Safe moisturizing alternatives include 100% pure sugarcane-derived squalane (a branched hydrocarbon, not a fatty acid) and mineral oil.
First-Line Antifungal Therapies
- Ketoconazole 2% (Shampoo/Cream): Apply as a 5-minute leave-on mask 3 times weekly.
- Zinc Pyrithione (1% - 2%): Effective broad-spectrum antifungal cleanser for daily use.
- Oral Fluconazole / Itraconazole: Prescribed in recalcitrant cases under dermatologist supervision.